Skip to main content
Clinical Trials/NL-OMON19926
NL-OMON19926
Completed
Not Applicable

Safety and Feasibility of End-ischemic Hypothermic Oxygenated Perfusion of Liver Grafts Donated after Circulatory Death in Liver Transplantation

niversity Medical Center GroningenHanzeplein 1P.O. Box 30.0019700 RB GroningenThe Netherlands0 sites6 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients with endstage liver disease who undergo liver transplantation with a graft from donation after circulatory death (DCD) donorDutch: Patiënten met eindstadium leverfalen die een lever transplantatie ondergaan met een lever afkomstig van een donor overleden na circulatiestilstand
Sponsor
niversity Medical Center GroningenHanzeplein 1P.O. Box 30.0019700 RB GroningenThe Netherlands
Enrollment
6
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversity Medical Center GroningenHanzeplein 1P.O. Box 30.0019700 RB GroningenThe Netherlands

Eligibility Criteria

Inclusion Criteria

  • Adult patients (\> 18 years old) awaiting a liver transplantation and who have been allocated a liver graft from a DCD (Maastricht type 3\) donor with a body weight of \> 40 kg

Exclusion Criteria

  • Patients with mental conditions rendering then incapable to understand the nature, scope and consequences of the trial; listed as high urgency; positive test for HIV; pregnant or nursing; donor positive for hepatitis B or C; expected cold ischemia time of \> 8 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials